Correlation Between Predictive Oncology and Sharps Technology

Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and Sharps Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and Sharps Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Predictive Oncology and Sharps Technology, you can compare the effects of market volatilities on Predictive Oncology and Sharps Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of Sharps Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and Sharps Technology.

Diversification Opportunities for Predictive Oncology and Sharps Technology

-0.33

Correlation Coefficient

Predictive Oncology  Sharps Technology

Very good diversification

The 3 months correlation between Predictive and Sharps is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and Sharps Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sharps Technology and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with Sharps Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sharps Technology has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and Sharps Technology go up and down completely randomly.

Pair Corralation between Predictive Oncology and Sharps Technology

Given the investment horizon of 90 days Predictive Oncology is expected to generate 22.95 times less return on investment than Sharps Technology. But when comparing it to its historical volatility, Predictive Oncology is 3.61 times less risky than Sharps Technology. It trades about 0.03 of its potential returns per unit of risk. Sharps Technology is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  383.00  in Sharps Technology on May 27, 2025 and sell it today you would earn a total of  771.00  from holding Sharps Technology or generate 201.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Predictive Oncology  vs.  Sharps Technology

Predictive Oncology

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Predictive Oncology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, Predictive Oncology may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Sharps Technology

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Sharps Technology are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Sharps Technology unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Predictive Oncology and Sharps Technology

The main advantage of trading using opposite Predictive Oncology and Sharps Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, Sharps Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sharps Technology will offset losses from the drop in Sharps Technology's long position.

The idea behind Predictive Oncology and Sharps Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..